1 |
电动苹果酒倒酒器 |
CN200620132861.6 |
2006-09-27 |
CN200988761Y |
2007-12-12 |
蒙特塞林·阿里亚斯·杰瑟斯 |
一种电动倒酒器包括一独立主体,在其底部装有一管状部件,通过该管状部件使倒酒器对应于瓶颈。在所述管状部件中,有一长条的抽水管沿中心向外延伸,从而穿进瓶中并且依靠主体内部的一个酒泵吸起瓶中液体,即利用推进力的方式将苹果酒强有力地射进玻璃杯中。 |
2 |
Nanocochleate formulations, process of preparation and method of
delivery of pharmaceutical agents |
US235400 |
1999-01-22 |
US6153217A |
2000-11-28 |
Tuo Jin; Leila Zarif; Raphael Mannino |
A process for producing a small-sized, lipid-based cochleate is described. Cochleates are derived from liposomes which are suspended in an aqueous two-phase polymer solution, enabling the differential partitioning of polar molecule based-structure by phase separation. The liposome-containing two-phase polymer solution, treated with positively charged molecules such as Ca.sup.2+ or Zn.sup.2+, forms a cochleate precipitate of a particle size less than one micron. The process may be used to produce cochleates containing pharmaceutical agents or biologically relevant molecules. Small-sized cochleates may be administered orally or through the mucosa to obtain an effective method of treatment. |
3 |
Insect repellent composition and method for inhibiting the transmission
and treatment of symptoms of vector-borne diseases |
US192421 |
1998-11-16 |
US5965137A |
1999-10-12 |
Edward J. Petrus |
A topical composition for the delivery of bio-affecting agents through the protective outer layer of skin into the underlying tissues and into the general circulation to prevent the causes and symptoms of vector-borne diseases. The transdermal penetration is achieved by the use of an essential volatile oil with insect repellent capabilities, such as eucalyptus oil. The bio-affective agents may be a combination of a zinc salt and form of vitamin A. A zinc salt may also be used for photoprotective purposes. The topical composition can be formulated as a solution, suspension, cream, ointment, gel, film or spray. |
4 |
Herbal composition for stimulating blood circulation |
US816936 |
1997-03-14 |
US5942233A |
1999-08-24 |
Teh Shan Chang |
This invention relates to an herb composition which comprises an amount of 30 to 45% by weight of one or more herbs for invigorating of blood circulation, an amount of 55 to 70% by weight of one or more herbs for excreting toxin from human body, and an amount of 0.5 to 4% by weight of one or more substances for keratin malacoma, all of which are based on the total weight of the composition, wherein the herb for invigorating of blood circulation is selected from the group consisting of Prunnus persica, south apricot kernel, white pepper (Piper migrum), glutinous rice (Oryza sativa) and white astragaluis (Common Bletillah Tuber); the herb for excreting toxin from human body is selected from the group consisting of Cassiope stelleriana, west carthamus (Crocus sativus), Lonicera japonica, rhubarb (Rheum officinale), Bezoar bovis, Liquorice powder (Glycyrrhiza uralensis), Salvia multiorrhiza, ligusticum (Cnidium officinale), Momordica cochinchinensis, achyranthes (Achyrathes bidentata) and astragalus (Astragalus hiroshimanus); and the substance for keratin malacoma is selected from the group consisting of vinegar, acetate salt, Szechwan notoginseng and Rehmannia glufinosa. This invention also relates to a paste containing the present herb composition which is produced by mixing the herb composition with vinegar, water or wine and optionally a binder. The paste is useful for reestablishing of vital energy, invigorating of blood circulation and elimination of blood stasis and for cold remedy by applying the paste on the sole of the human's foot. |
5 |
Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of
pharmaceutical compounds |
US973593 |
1998-02-11 |
US5916566A |
1999-06-29 |
Leslie Z. Benet; Vincent J. Wacher; Reed M. Benet |
A method for increasing bioavailabilty of an orally administered hydrophobic pharmaceutical compound, which comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently with an essential oil or essential oil component in an amount sufficient to provide bioavailability of the compound in the presence of the essential oil or essential oil component greater than bioavailability of the compound in the absence of the essential oil or essential oil component, wherein the essential oil or essential oil component has an activity of at least 10% inhibition at a concentration 0.01 wt. % or less in an assay that measures reduced conversion of cyclosporine to hydroxylated products using an assay system containing 250 .mu.g rat liver microsomes, 1 .mu.M cyclosporine, and 1 .mu.M reduced nicotinamide adenine dinucleotide phosphate (NADPH) in 1 ml of 0.1 M sodium phosphate buffer, pH 7.4. |
6 |
Processed ginseng product with enhanced pharmacological effects |
US660448 |
1996-06-07 |
US5776460A |
1998-07-07 |
Nak Doo Kim; Man Ki Park; Seung Ki Lee; Jeong Hill Park; Jong Moon Kim |
A processed ginseng product with enhanced pharmacological effects is provided due to a heat-treatment at a high temperature of 120.degree. to 180.degree. C. for 0.5 to 20 hours so as to make a ratio of ginsenoside (Rg.sub.3 +Rg.sub.5) to (Rc+Rd+Rb.sub.1 +Rb.sub.2) above 1.0. |
7 |
Pharmaceutical composition for increasing immunity and decreasing side
effects of anticancer chemotherapy |
US732146 |
1985-05-09 |
US4687761A |
1987-08-18 |
Yaguang Liu |
A new pharmaceutical composition for treatment and prevention of side effects of anticancer chemotherapy and radiotherapy and increasing the immune function contains Ferulic acid, Ginsenoside, Anethole and sodium Cinnamate. Processes for producing these components and related pharmacological effect are provided. |
8 |
Preparation for deactivating viruses and process for producing same |
US706470 |
1985-02-28 |
US4595593A |
1986-06-17 |
Erich Wolf; Andreas Lembke; Rolf Deininger |
The invention relates to a process and a preparation for deactivating viruses inside living human and animal organisms by application of a terpene obtainable from aromatic plants by steam distillation. The terpenes cited are: black pepper oil, cinnamon flower oil, cardamom oil, linallyl acetate, cinnamic aldehyde, safrol, carvon and cis/trans citral. |
9 |
Anti-acne composition |
US553977 |
1983-11-21 |
US4545990A |
1985-10-08 |
Carol Le Foyer de Costil; Liliane Ayache; Jean-Paul Tisseyre |
A composition for the local treatment of acne comprises from 1 to 20 weight percent of benzoyl peroxide and at least one other active principle selected from collagenic palmitoyl acid, glycyrrhetinic acid, bisabolol and a meristem extract. |
10 |
Process and preparation for deactivating viruses |
US184135 |
1980-09-04 |
US4402950A |
1983-09-06 |
Erich Wolf; Andreas Lembke; Rolf Deininger |
The invention relates to a process and a preparation for deactivating viruses inside living human and animal organisms by application of a terpene obtainable from aromatic plants by steam distillation. The terpenes cited are: black pepper oil, cinnamon flower oil, cardamon oil, linallyl acetate, cinnamic aldehyde, safrol, carvon and cis/trans citral. |
11 |
Therapeutic agent for the external treatment of psoriasis, tinea and
eczemas |
US33154 |
1979-04-25 |
US4235889A |
1980-11-25 |
Walter Evers |
The subject of the invention is a pharmaceutical composition for the external treatment of psoriasis, tinea and eczemas, comprising coconut oil, palm kernel oil, an extract of Laurus nobilis (Linn.) and an emulsifier. |
12 |
Brough |
US469850D |
|
US469850A |
1892-03-01 |
|
|
13 |
Aaron rosenberg |
US444398D |
|
US444398A |
1891-01-06 |
|
|
14 |
Liniment |
US416409D |
|
US416409A |
1889-12-03 |
|
|
15 |
Eye-salve |
US392904D |
|
US392904A |
1888-11-13 |
|
|
16 |
Composition for cleaning and preserving carpets |
US392205D |
|
US392205A |
1888-11-06 |
|
|
17 |
Ohaeles p |
US327883D |
|
US327883A |
1885-10-06 |
|
|
18 |
Bitters |
US327603D |
|
US327603A |
1885-10-06 |
|
|
19 |
joslin tueneb |
US260140D |
|
US260140A |
1882-06-27 |
|
|
20 |
Bitters |
US238581D |
|
US238581A |
1881-03-08 |
|
|